Medical Devices conference, held in Munich, Germany on 28-29 January, was filled with sessions that dug into the minutiae of ...

US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

According to leading data and analytics company GlobalData’s Clinical Trials Database, over the past 20 years trial activity ...

Paradigm Biopharmaceuticals has selected Advanced Clinical as the CRO to support its Phase III trial, PARA_OA_012, focused on ...

A study from the University of Birmingham has indicated that digoxin could be used to treat senior individuals with heart ...

Ryght AI has partnered with Cancer Research South Australia (CRSA) to advance cancer clinical trials and expand patient ...

MindMed has dosed the first subject in the Phase III Panorama study of MM120 ODT for the treatment of generalised anxiety ...

Kashiv Biosciences has reported that a trial of its 125mg/mL pre-filled syringe injection, KSHB002, has achieved its primary ...

MM PD market growth will be driven by advancements in innovative therapies, including the first DMTs, and a growing patient ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.

MSD said that its sotatercept steering committee called for the trial to end as patients are moved to the ongoing open-label ...

Arena International’s Outsourcing in Clinical Trials West Coast 2025 will discuss patient centricity, diversity, and ...